SAN DIEGO--(BUSINESS WIRE)--Sep. 12, 2018--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the only touchscreen insulin pumps with continuous
glucose monitoring integration, today announced it will host an
Institutional Investor and Analyst Day from 8:30am to 1:00pm Pacific
Time on Tuesday, September 25, 2018 in San Diego, California. The
program will include presentations regarding the Company’s longer-term
vision, product pipeline, and international expansion. In addition,
presentations will be given by clinical and industry experts on the
subject of automated insulin delivery (AID). The Company will also host
a healthcare provider and patient panel, provide product demonstrations,
and will offer tours of its new manufacturing facility.
Institutional investors and analysts are invited to attend live and are
encouraged to register in advance at http://investor.tandemdiabetes.com/institutional-investor-analyst-day.
A live webcast and archived recording of the presentations by members of
management and clinical and industry thought leaders will be accessible
on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com
in the “Events & Presentations” section. The remainder of the event will
not be webcast. An archive of the recorded portion of the event will be
available for 30 days.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach to
the design, development and commercialization of products for people
with diabetes who use insulin. Tandem manufactures and sells the t:slim
X2™ Insulin Pump with Basal-IQ™ technology. The t:slim X2 Pump is
capable of remote feature updates using a personal computer and is the
only automated insulin delivery device approved for children as young as
6 years old. Tandem is based in San Diego, California.
Tandem Diabetes Care is a registered trademark, and t:slim X2 and
Basal-IQ are trademarks of Tandem Diabetes Care, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180912005387/en/
Source: Tandem Diabetes Care, Inc.
For Tandem Diabetes Care, Inc.
Media Contact:
Steve
Sabicer, 714-907-6264
ssabicer@thesabicergroup.com
or
Investor
Contact:
Susan Morrison, 858-366-6900 x7005
ir@tandemdiabetes.com
